Bristol-myers Squibb Company Company Profile
✉ Email this page to a colleague
Summary for Bristol-myers Squibb Company
Patents: | 0 |
Tradenames: | 6 |
Ingredients: | 6 |
BLAs: | 6 |
Biologic Drugs for Bristol-myers Squibb Company
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bristol-myers Squibb Company | ORENCIA | abatacept | For Injection | 125118 | 2005-12-23 | ⤷ Subscribe | |
Bristol-myers Squibb Company | NULOJIX | belatacept | For Injection | 125288 | 2011-06-15 | ⤷ Subscribe | |
Bristol-myers Squibb Company | YERVOY | ipilimumab | Injection | 125377 | 2011-03-25 | ⤷ Subscribe | |
Bristol-myers Squibb Company | OPDIVO | nivolumab | Injection | 125554 | 2014-12-22 | ⤷ Subscribe | |
Bristol-myers Squibb Company | EMPLICITI | elotuzumab | For Injection | 761035 | 2015-11-30 | ⤷ Subscribe | |
Bristol-myers Squibb Company | OPDUALAG | nivolumab and relatlimab-rmbw | Injection | 761234 | 2022-03-18 | ⤷ Subscribe | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |